Document is current
Any future updates will be listed below
-
Authors
Bronton, Kevin https://orcid.org/0000-0001-5876-2655
Wessman, Torgny https://orcid.org/0000-0002-7314-2240
Gränsbo, Klas
Schulte, Janin
Hartmann, Oliver
Melander, Olle https://orcid.org/0000-0002-2581-484X
-
Funding
Funding for this research was provided by:
Hjärt-Lungfonden (20180278)
Vetenskapsrådet (2018-02760)
Lund University
- License Information
-
More Information
Article History
Received: 11 March 2021
Accepted: 24 May 2021
First Online: 26 June 2021
Declarations
:
: SphingoTec GmbH is the manufacturer of the bio-ADM assay and facilitated transport and analysis of bio-ADM and NT-proBNP in the study samples. Schulte and Hartman are employees of Sphingotec GmbH. Melander is listed as an inventor on a patent application owned by SphingoTec GmbH regarding the use of bio-ADM in the prediction and diagnosis of dementia. The remaining authors have no conflicts of interest to declare.
: This study was performed in line with the principles of the declaration of Helsinki. Approval was granted by the Regional Ethical Review Board in Lund (Dnr 2012/762).
: We obtained both written and oral consent from all participants.
